Invesaro

Stocks Health care FRNM

NASDAQ · Health care

Freenome, Inc. (FRNM)

It posted a net loss of $762.6K. At June 30, 2026 it held $437.4K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 15, 2026.

What Freenome, Inc. does

Freenome, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker FRNM.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$3M$837.5Kn/an/a

Latest SEC filings

What Freenome, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 23, 2026
  2. September 1, 2026
  3. August 27, 2026
  4. August 18, 2026
  5. August 14, 2026
  6. August 14, 2026
  7. August 13, 2026
  8. August 12, 2026
  9. August 12, 2026
  10. August 5, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 4, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about FRNM

What does Freenome, Inc. do?

Freenome, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker FRNM.

Is Freenome, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $762.6K.

When did Freenome, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 15, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from September 23, 2026.

Similar companies

Follow FRNM

Get an email when Freenome, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow FRNM: get an email when it files

Where the numbers come from

Financial figures are the values Freenome, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.